A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood
1997

Detecting Carcinoma Cells in Blood Using RT-PCR

Sample size: 7 publication Evidence: moderate

Author Information

Author(s): W Helfrich, R ten Poele, GJ Meersma, NH Mulder, EGE de Vries, L de Leij, EF Smit

Primary Institution: University Hospital Groningen

Hypothesis

The presence of carcinoma cells in peripheral blood can predict disease recurrence and metastasis.

Conclusion

A sensitive quantitative RT-PCR assay was developed to detect carcinoma cells in peripheral blood, which may help in predicting disease recurrence.

Supporting Evidence

  • The assay can detect as few as ten carcinoma cells among 1.0 x 10^6 leukocytes.
  • Normal bone marrow expresses low levels of EGP2 mRNA.
  • EGP2 is a pancarcinoma-associated glycoprotein expressed in many carcinomas.

Takeaway

Scientists created a test to find cancer cells in blood, which can help doctors know if a patient might get sick again.

Methodology

The study used a quantitative RT-PCR assay to detect EGP-2 mRNA in blood and bone marrow samples.

Limitations

The assay may detect illegitimate transcription of EGP2 in normal cells, complicating the interpretation of results.

Participant Demographics

Seven healthy volunteers provided blood samples.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication